{"id":"W2765867855","doi":"10.1111/cas.13427","title":"Everolimus in advanced, progressive, well‐differentiated, non‐functional neuroendocrine tumors: <scp>RADIANT</scp>‐4 lung subgroup analysis","year":2017,"lang":"en","type":"article","venue":"Cancer Science","topic":"Neuroendocrine Tumor Research Advances","field":"Medicine","cited_by":102,"is_retracted":false,"has_abstract":true,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre","funders":"Novartis Pharmaceuticals Corporation","keywords":"Everolimus; Medicine; Placebo; Clinical endpoint; Hazard ratio; Internal medicine; Gastroenterology; Adverse effect; Oncology; Subgroup analysis; Surgery; Confidence interval; Randomized controlled trial; Pathology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0002429513,0.0003780175,0.000679802,0.001196246,0.0008206912,0.0003589925,0.001313945,0.00001176388,0.0002409286],"category_scores_gemma":[0.001482736,0.0003313487,0.0002074186,0.002508647,0.001598457,0.001562639,0.0005104286,0.0006346984,0.00006405653],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004223572,"about_ca_system_score_gemma":0.0008320148,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0003758473,"about_ca_topic_score_gemma":0.0004276064,"domain_scores_codex":[0.995051,0.00005323246,0.000480152,0.001351562,0.001550673,0.0015134],"domain_scores_gemma":[0.9969142,0.0001471288,0.000393009,0.001487311,0.0003142788,0.0007440805],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0001780893,0.0002728152,0.9682672,0.0001362452,0.0001099506,0.007963642,0.00006497564,0.001140283,0.01727177,0.00008456554,0.0009317093,0.003578739],"study_design_scores_gemma":[0.002468584,0.0002434349,0.9567552,0.0002033056,0.0001603997,0.0004731368,0.00008529022,0.01250982,0.0251033,0.0000706978,0.001771123,0.0001557249],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.99298,0.001304971,0.0001004065,0.001164266,0.0006158957,0.0008392133,0.00002114694,0.00008863353,0.002885447],"genre_scores_gemma":[0.9952807,0.0004911923,0.000299798,0.0003432939,0.0002000783,0.000335521,0.00001313967,0.0000374159,0.002998887],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.01151203,"threshold_uncertainty_score":0.9999139,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02009855395982761,"score_gpt":0.3434529611111763,"score_spread":0.3233544071513487,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}